Details of Drug-Drug Interaction
| Drug General Information (ID: DDIURPYQNI) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Conjugated estrogens | Drug Info | Levothyroxine | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Estrogens | Antithyroid Agents | |||||||
| Structure | |||||||||
| Mechanism of Conjugated estrogens-Levothyroxine Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Increase globulin concentration Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Conjugated estrogens | Levothyroxine | |||||||
| Mechanism | Increase serum thyroid-binding globulin concentration | Thyroid hormone | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacokinetics | ||||||||
| Factor Description | Alters the distribution of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | In patients treated with thyroxine, serum thyrotropin should be measured approximately 12 weeks after estrogen therapy is initiated, changed or discontinued, and the thyroxine dosage adjusted accordingly. Patients should be advised to contact their physician if clinical manifestations of hypothyroidism occur, such as fatigue, cold intolerance, constipation, unexplained weight gain, depression, joint or muscle pain, thinning hair or hair loss, dry skin, hoarseness, and abnormal menstrual periods. | ||||||||

